FEBS Letters · 2014 · 44 citations · 24 references
Life SciencesMolecular BiologyOncologyGene ExpressionMolecular OncologyTumor ProgressionGlioblastomaMicrorna BiologyMicrorna-mediated RegulationOncogenic Signaling PathwaysSignal Transduction In CancerWnt SignalingBeta-catenin RegulationCanonical Wnt PathwayMicrorna In CancerMicrorna-mediated Pathway RegulationWnt In CancerWnt Signal TransductionWnt Signaling ActivationWnt Signaling In Proliferation
We found that miR-96 is overexpressed in glioma, and its level inversely correlates with the survival of patients. The reduction in miR-96 abundance suppresses the proliferation and colony formation of glioma cells. The tumorigenicity of U-87 MG cells is reduced by miR-96 silencing. miR-96 contributes to the activation of Wnt/β-catenin pathway in glioma cells. HMG-box transcription factor 1 (HBP-1), a Wnt/β-catenin pathway inhibitor, is suppressed by miR-96. The reactivation of Wnt/β-catenin signaling causes an increase in the proliferation of glioma cells, and a decrease in miR-96 expression. On the other hand, HBP1 silencing promotes miR-96 expression. Collectively, miR-96 contributes to the progression of glioma by enhancing the activation of the Wnt/β-catenin pathway, and the miR-96/HBP1/Wnt/β-catenin regulatory circuitry promotes the proliferation of glioma cells.
24
miRNA-96 Suppresses KRAS and Functions as a Tumor Suppressor Gene in Pancreatic Cancer
Shuangni Yu, Zhaohui Lu, Changzheng Liu et al. · Cancer Research · 2010 · 326 citations